BPA
TIL icon

Beacon Pointe Advisors’s Instil Bio TIL Stock Holding History

Beacon Pointe Advisors’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,849
Closed -$326K – 1278
2024
Q3 		$326K Buy
+4,849
New +$114K ﹤0.01% 991
2023
Q4 		– Sell
-4,850
Closed -$41.5K – 1393
2023
Q3 		$41.5K Buy
+4,850
New +$48.9K ﹤0.01% 1313
2021
Q4 		– Sell
-4,890
Closed -$1.75M – 1004
2021
Q3 		$1.75M Buy
+4,890
New +$1.83M 0.04% 298

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Beacon Pointe Advisors's TIL Position: Q4 2024 in Review

Beacon Pointe Advisors sold out of Instil Bio (TIL) in Q4 2024, closing a stake of 4,849 shares — an estimated $326K sold.

Beacon Pointe Advisors first reported a position in TIL in Q3 2021 and held it in 3 quarters. The position peaked at $1.75M in Q3 2021. 40 funds tracked by Wall St. Rank hold TIL as of Q4 2024.

  • Beacon Pointe Advisors reported no remaining Instil Bio position as of Q4 2024 after selling out during the quarter.
  • Beacon Pointe Advisors sold 4,849 Instil Bio shares in Q4 2024, an estimated $326K.
  • Beacon Pointe Advisors first reported a position in Instil Bio in Q3 2021 and held it in 3 quarters.
  • Beacon Pointe Advisors's Instil Bio position peaked at $1.75M in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Instil Bio as of Q4 2024.

Based on Beacon Pointe Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.